Jacob Hughes
Stock Analyst at Wells Fargo
(1.35)
# 3,287
Out of 4,832 analysts
27
Total ratings
50%
Success rate
-1.31%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Jacob Hughes
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AMPH Amphastar Pharmaceuticals | Maintains: Equal-Weight | $40 → $44 | $23.30 | +88.84% | 5 | May 17, 2023 | |
| PRGO Perrigo Company | Upgrades: Overweight | $54 | $26.01 | +107.61% | 1 | Sep 6, 2022 | |
| IRWD Ironwood Pharmaceuticals | Maintains: Equal-Weight | $12 → $13 | $0.65 | +1,903.08% | 3 | Aug 16, 2022 | |
| MDWD MediWound | Maintains: Overweight | $49 → $56 | $19.39 | +188.81% | 1 | May 18, 2022 | |
| EBS Emergent BioSolutions | Maintains: Equal-Weight | $46 → $38 | $5.64 | +573.76% | 3 | May 4, 2022 | |
| TEVA Teva Pharmaceutical Industries | Maintains: Equal-Weight | $12 → $11 | $16.89 | -34.87% | 11 | Jul 29, 2021 | |
| BHC Bausch Health Companies | Maintains: Equal-Weight | $18 → $17 | $4.56 | +272.81% | 3 | Oct 28, 2020 |
Amphastar Pharmaceuticals
May 17, 2023
Maintains: Equal-Weight
Price Target: $40 → $44
Current: $23.30
Upside: +88.84%
Perrigo Company
Sep 6, 2022
Upgrades: Overweight
Price Target: $54
Current: $26.01
Upside: +107.61%
Ironwood Pharmaceuticals
Aug 16, 2022
Maintains: Equal-Weight
Price Target: $12 → $13
Current: $0.65
Upside: +1,903.08%
MediWound
May 18, 2022
Maintains: Overweight
Price Target: $49 → $56
Current: $19.39
Upside: +188.81%
Emergent BioSolutions
May 4, 2022
Maintains: Equal-Weight
Price Target: $46 → $38
Current: $5.64
Upside: +573.76%
Teva Pharmaceutical Industries
Jul 29, 2021
Maintains: Equal-Weight
Price Target: $12 → $11
Current: $16.89
Upside: -34.87%
Bausch Health Companies
Oct 28, 2020
Maintains: Equal-Weight
Price Target: $18 → $17
Current: $4.56
Upside: +272.81%